BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 17227206)

  • 1. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
    Deshpande LM; Jones RN; Fritsche TR; Sader HS
    Microb Drug Resist; 2006; 12(4):223-30. PubMed ID: 17227206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).
    Deshpande LM; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):367-72. PubMed ID: 17020798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
    Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
    Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
    Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
    BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem non-susceptible enterobacteriaceae in Quebec, Canada: results of a laboratory surveillance program (2010-2012).
    Lefebvre B; Lévesque S; Bourgault AM; Mulvey MR; Mataseje L; Boyd D; Doualla-Bell F; Tremblay C
    PLoS One; 2015; 10(4):e0125076. PubMed ID: 25910041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
    Lee HK; Park YJ; Kim JY; Chang E; Cho SG; Chae HS; Kang CS
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular study of carbapenemase genes in clinical isolates of Enterobacteriaceae resistant to carbapenems and determining their clonal relationship using pulsed-field gel electrophoresis.
    Shahcheraghi F; Aslani MM; Mahmoudi H; Karimitabar Z; Solgi H; Bahador A; Alikhani MY
    J Med Microbiol; 2017 May; 66(5):570-576. PubMed ID: 28485708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).
    Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Oct; 83(2):183-6. PubMed ID: 26164275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates.
    Pena I; Picazo JJ; Rodríguez-Avial C; Rodríguez-Avial I
    Int J Antimicrob Agents; 2014 May; 43(5):460-4. PubMed ID: 24657043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the modified Hodge test and the Carba NP test for detection of carbapenemases in Enterobacteriaceae isolates].
    Bayramoğlu G; Uluçam G; Gençoğlu Özgür Ç; Kılıç AO; Aydın F
    Mikrobiyol Bul; 2016 Jan; 50(1):1-10. PubMed ID: 27058324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China.
    Zhou T; Zhang X; Guo M; Ye J; Lu Y; Bao Q; Chi W
    Jpn J Infect Dis; 2013; 66(2):96-102. PubMed ID: 23514904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
    Rimrang B; Chanawong A; Lulitanond A; Wilailuckana C; Charoensri N; Sribenjalux P; Phumsrikaew W; Wonglakorn L; Kerdsin A; Chetchotisakd P
    J Antimicrob Chemother; 2012 Nov; 67(11):2626-30. PubMed ID: 22796889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
    Çakar A; Akyön Y; Gür D; Karatuna O; Öğünç D; Özhak Baysan B; Çöplü N; Çağatay M; Kılıç A; Baysallar M; Bakıcı Z; Çelik C; Gülay Z; Aydemir Ş; Tünger A; Kılıç H; Erçal BD; Aşçı Toraman Z; Zer Y; Büyüktaş A; Ay S; Aktaş Z; Kayacan Ç; Bayramoğlu G; Aydın F; Dündar D; Hasdemir U; Ayaş R; Yanık K; Günaydın M; Güdücüoğlu H; Parlak M
    Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
    Demir Y; Zer Y; Karaoglan I
    Pak J Pharm Sci; 2015 May; 28(3 Suppl):1127-33. PubMed ID: 26051720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of the modified Hodge test and carbapenemase inhibition test for detection of carbapenemase-producing Enterobacteriaceae and metallo-β-lactamase-producing Pseudomonas spp.
    Song W; Hong SG; Yong D; Jeong SH; Kim HS; Kim HS; Kim JS; Bae IK
    Ann Lab Med; 2015 Mar; 35(2):212-9. PubMed ID: 25729723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014.
    Jayol A; Poirel L; Dortet L; Nordmann P
    Euro Surveill; 2016 Sep; 21(37):. PubMed ID: 27685838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.